Skip to content
StockMarketAgent

C vs JPM: side-by-side analysis

Cross-read of C (Citigroup Inc.) versus JPM (JPMorgan Chase & Co.): C looks meaningfully overvalued at $130 versus a fair-value midpoint of $87.0, while JPM appears in our peer table at a forward P/E of 13.0x and ROE of 16.5%. Our current rating for C is Sell.

Where C and JPM sit on fair value

C's composite fair-value range is $53.5–$116 (midpoint $87.0), versus a current price of $130. JPM is one of C's closest sector neighbours and shows up directly in the peer table inside our full report, with a market-cap of $820.7B, P/E of 13.0x, EV/EBITDA of , and an operating margin of 43.7%. The cross-read is editorial: same archetype expectations, same discount-rate philosophy, different operating model.

Both names are evaluated under the same six-factor decision overlay (customer value, unit economics, TAM, moat durability, risk profile, valuation) so comparing them is apples-to-apples rather than headline-multiple-to-headline-multiple. The rating differential between C and JPM is driven by where each lands across those six axes, not by who looks "cheaper" on a single screen.

Where they actually differ

C is classified as a financial stock; the archetype dictates our deceleration curve, terminal multiple, and probability weights. JPM, depending on its own archetype, will have its own calibration — and that is precisely why simple peer multiples can mislead. A 10.5× forward P/E with a PEG of 2.62 is not the same on C as it is on JPM unless they share the same growth profile, capital intensity, and moat half-life.

C's moat assessment is 3/10, and the full moat section in the report covers the source (network effects, switching costs, intangibles, scale, etc.) plus the timeline of any threats. The cross-read against JPM should focus on which company's economic profit (ROIC minus WACC) is wider AND more durable — that is the variable that dominates long-run total return between two same-sector names.

Which one wins on each dimension

Valuation: C looks meaningfully overvalued versus our fair-value midpoint. The full report's peer table compares C and JPM directly on P/E, PEG, EV/EBITDA, ROE, and operating margin. Risk: the bear case for C is bound by the kill-scenarios list in Section 2; the equivalent for JPM would need its own report. We do not co-rate two companies on a single page.

Capital allocation and growth runway typically separate same-sector pairs more than the headline numbers suggest. The full report's capital-allocation paragraph and TAM analysis are the lenses we recommend before deciding whether C or JPM is the better expression of the same theme.

Bottom line — C or JPM?

Our rating for C is Sell with a 73/100 confidence score; the rating already accounts for the relative-value information embedded in the peer table that includes JPM. The cross-read is most useful when the two companies are real substitutes in a portfolio (same factor exposure, same end markets, same archetype) — otherwise the comparison is theatre.

For the full evidence on C, including the explicit peer multiples versus JPM and the rest of the comp set, see the canonical report at /stocks/c/analysis. For JPM's standalone report, see /stocks/jpm/analysis.

Frequently asked questions

C vs JPM: which is cheaper today?

C looks meaningfully overvalued at $130 versus a fair-value midpoint of $87.0 (range $53.5–$116). The peer table inside the full report compares C and JPM directly on P/E, PEG, EV/EBITDA, ROE, and operating margin.

Is C a better buy than JPM?

Our current rating for C is Sell; we do not co-rate JPM on this page — see JPM's own report. The cross-read is most useful for relative positioning, not for choosing one over the other in isolation.

What archetype is C?

Citigroup Inc. is classified as a financial stock, which determines our deceleration curve, terminal multiple, and probability weights. JPM's own archetype is in its own report.

What is C's moat score versus JPM?

C's moat score is 3/10. The full moat section covers source, durability, and threat timeline; JPM's moat assessment is in its own standalone report.

Research for educational purposes. Not personalised investment advice. See the full C report for the canonical evidence.